Search Results - "Epstein, Lauren H"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    14-Year Epidemiologic study of Pseudomonas aeruginosa bloodstream infection incidence and resistance in the Veterans Health Administration system, 2009–2022 by Hojat, Leila S, Wilson, Brigid M, Satlin, Michael J, Perez, Federico, Mojica, Maria F, Singer, Mendel E, Bonomo, Robert A, Epstein, Lauren H

    Published in JAC-antimicrobial resistance (01-04-2024)
    “…Abstract Background Multidrug resistant Pseudomonas aeruginosa (PA) represents a serious threat to hospitalized patients. Characterizing the incidence of PA…”
    Get full text
    Journal Article
  3. 3

    Evaluation of programmatic changes to an antimicrobial stewardship program with house officer feedback by Hong, Steven Y., Epstein, Lauren H., Lawrence, Kenneth, Davidson, Lisa, Taur, Ying, Nadkarni, Lauren, Doron, Shira

    Published in Journal of evaluation in clinical practice (01-04-2013)
    “…Rationale, aims and objectives  A collegial relationship between prescribers and antimicrobial stewards, along with an appreciation of the importance of…”
    Get full text
    Journal Article
  4. 4

    Using Active Surveillance to Identify Monoclonal Antibody Candidates Among COVID-19-Positive Veterans in the Atlanta VA Health Care System by DeSilva, Kathryn E, Paras, Alexander T, Goolsby, Tiffany A, Chan, Bonnie J, Epstein, Lauren H, Harris, Nadine M, Cartwright, Emily J, Moanna, Abeer, Oliver, Nora T

    Published in Federal practitioner (01-09-2023)
    “…Strategies for optimizing identification and outreach to potential candidates for monoclonal antibody (Mab) therapy for COVID-19 are not clear. Using a…”
    Get full text
    Journal Article
  5. 5

    1301. Assessing Safety and Clinical Outcomes of Outpatient Parenteral Antimicrobial Program in Veterans by Rich, William, Epstein, Lauren H, Oliver, Nora T

    Published in Open forum infectious diseases (27-11-2023)
    “…Abstract Background Outpatient parenteral antimicrobial therapy (OPAT) is administering intravenous antibiotics in the outpatient setting. Herein we wish to…”
    Get full text
    Journal Article
  6. 6

    617. Long Acting Lipoglycopeptide Use in Veterans for Serious Gram-Positive Infections in the COVID Era by Saldana, Carlos S, Goolsby, Tiffany, Epstein, Lauren H, Oliver, Nora

    Published in Open forum infectious diseases (04-12-2021)
    “…Abstract Background Dalbavancin and Oritavancin are semisynthetic lipoglycopeptides (LGP) that are FDA-approved for treatment of skin and soft tissue…”
    Get full text
    Journal Article
  7. 7

    170. Comparison of Traditional Stool Culture and Targeted Testing Using Multiplex PCR to Diagnose Infectious Diarrhea at the Atlanta VA Medical Center (AVAMC): A Diagnostic Stewardship Initiative by Molinari, Alexander H, Epstein, Lauren H, Darius, Nicole, Goolsby, Tiffany, Webster, Andrew S

    Published in Open forum infectious diseases (15-12-2022)
    “…Abstract Background Multiplex PCR panels have become common for diagnosing infectious diarrhea; however, indiscriminate use of multiplex PCR panels may…”
    Get full text
    Journal Article
  8. 8

    1885. Experience using combined antigen and RT-PCR tests for COVID-19 diagnosis at a Veterans Affairs (VA) Health Care System during the Omicron surge by Chirumamilla, Siri, Powell, Krista, Gutman, David, Webster, Andrew S, Moanna, Abeer, Epstein, Lauren H

    Published in Open forum infectious diseases (15-12-2022)
    “…Abstract Background Combining rapid antigen and RT-PCR tests optimizes detection of COVID-19 compared with either test alone. Therefore, coincident with the…”
    Get full text
    Journal Article
  9. 9
  10. 10

    544. Using Active Surveillance to Identify Monoclonal Antibody Candidates Among COVID-19 Positive Veterans, Atlanta VA Healthcare System by Paras, Alexander T, DeSilva, Kathryn E, Oliver, Nora T, Epstein, Lauren H, Harris, Nadine M, Cartwright, Emily J, Moanna, Abeer

    Published in Open forum infectious diseases (04-12-2021)
    “…Abstract Background Monoclonal antibody (Mab) infusions have reduced hospitalization and mortality among higher risk patients with mild to moderate COVID-19…”
    Get full text
    Journal Article
  11. 11